AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Over

Corteva Agriscience (NYSE: CTVA) is een pure-play landbouwbedrijf en een van 's werelds toonaangevende leveranciers van zaad- en gewasbeschermingsproducten, afgesplitst van DowDuPont in 2019 om zich uitsluitend te richten op het bevorderen van de agrarische productiviteit. Het zaadsegment van het bedrijf biedt een breed portfolio aan kiemplasma en eigenschappen in maïs, soja en andere gewassen onder de merken Pioneer en Brevant, terwijl het gewasbeschermingssegment herbiciden, insecticiden en fungiciden aan boeren wereldwijd levert. Corteva's toegewijde focus op landbouwinnovatie, inclusief digitale landbouwtools en biologische gewasoplossingen, positioneert het als een directe investering in de toekomst van voedselproductie en duurzame landbouwpraktijken.

Landbouwaandelen

Corteva Agriscience is een puur landbouwbedrijf dat zich richt op zaadgenetica en gewasbeschemingsproducten, wat beleggers directe blootstelling biedt aan innovatie op boerderijenniveau, inclusief geavanceerd kiemplasma, kenmerktechnologieën en duurzame landbouwoplossingen.

AgriTech-aandelen

Corteva is een puur landbouwbedrijf en toonaangevende wereldwijde leverancier van zaad- en gewasbeschemingsproducten, afgesplitst van DowDuPont om zich op landbouwinnovatie en -productiviteit te concentreren.

Key Financials CTVA

Prijs $75.03
Wijziging (1D) +1.24%
Wijziging (30D) +11.93%
Wijziging (60D) +17.45%
Wijziging (90D) +16.69%
Wijziging (180D) +6.70%
Wijziging (1Y) +20.90%
Wijziging (5Y) +72.76%
P/E-verhouding 24.36
EPS (TTM) $3.08
52-weekse bandbreedte $53.40 — $77.41
50-daags MA $69.55
Volume 3.50M

Data updated Feb 15 · Source: Twelve Data

4.5
2 reviews
Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Claude Opus 4.6
AI Review
4.4/5

Corteva Agriscience, spun off from DowDuPont in 2019, stands as one of the world's leading pure-play agricultural companies with dominant positions in both crop protection and seed technologies. The stock has shown strong momentum, trading near its 52-week high of $77.41 with a 20.9% gain over the past year and impressive 72.8% appreciation over five years.

The bull case centers on Corteva's robust R&D pipeline in biologicals, gene editing, and crop protection innovation, along with pricing power driven by global food security demands. Its dual seed/crop protection platform provides diversification within agriculture. EPS of $3.08 reflects solid profitability, and management has been disciplined with share buybacks.

The bear case includes a P/E of 24.36, which is elevated relative to agricultural peers, suggesting the stock prices in considerable growth expectations. Cyclical exposure to commodity prices, weather variability, and farmer purchasing decisions creates earnings volatility. Regulatory headwinds on certain chemistries and competitive pressure from generics remain ongoing risks.

Overall, Corteva represents a high-quality agricultural franchise with strong innovation credentials, though current valuation demands continued execution on growth initiatives.

Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.6/5

Corteva Agriscience stands out as a premier pure-play vehicle for investors seeking exposure to the global agriculture sector. Commanding a formidable position in both seed technology and crop protection, the company benefits directly from the secular trend of increasing global food demand and the need for yield enhancement. With the stock trading near its 52-week high of $77.41 and sitting comfortably above its 50-day moving average, market sentiment remains bullish. The current P/E ratio of 24.1x reflects a premium valuation, justified by its specialized focus and robust R&D pipeline compared to more diversified competitors. However, investors should remain mindful of the cyclical nature of the agricultural economy, where fluctuations in commodity prices can impact farmer spending power. Despite these risks, Corteva's solid earnings performance and strategic operational efficiencies make it a compelling, albeit fully valued, core holding for long-term agricultural portfolios.

Feb 11, 2026
Corteva Agriscience Screenshot

Added: Feb 10, 2026

corteva.com

Latest from Otrai